|Bid||0.0000 x 0|
|Ask||0.0000 x 0|
|Day's Range||0.0980 - 0.1190|
|52 Week Range||0.0900 - 0.4900|
|Beta (5Y Monthly)||2.08|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Subscribe to Yahoo Finance Plus to view Fair Value for BUDZ
WEED, Inc. (OTCQB:BUDZ) ("WEED" or the "Company") a global cannabis & hemp bioresearch company based in the USA, focused on the development and application of cannabis-derived compounds for the treatment of human and animal diseases, announced today that it acquired 100% of Hempirical Genetics, LLC, for 2 million shares of common stock valued at $.25 per share and $250,000 in cash over 4 years.
, w/non-profit arm, The Cannabis Institute of Australia, is attending the United in Compassion Australian Medicinal Cannabis Symposium May 20-22, 2022 on the sunshine coast in northern Queensland.TUCSON, AZ / ACCESSSWIRE / May 4, 2022 / WEED, Inc.
is a majority (>99%) owned subsidiary of WEED, Inc (USA) and one of the first public Cannabis companies in Australia established in March 2017.TUCSON, AZ / ACCESSWIRE / May 3, 2022 / WEED, Inc.